Table 3 The performance of 5-miRPairs in predicting other cancer types
From: Construct of qualitative diagnostic biomarkers specific for glioma by pairing serum microRNAs
Cancer type | GSE113486 | GSE112264 | GSE113740 | |||
|---|---|---|---|---|---|---|
No. | Percentagea | No. | Percentage | No. | Percentage | |
Bladder Cancer | 370 | 91.08% | 48 | 87.50% | 24 | 95.83% |
Breast Cancer | 37 | 94.59% | – | – | 24 | 95.83% |
Biliary Tract Cancer | 39 | 94.87% | 48 | 95.83% | 25 | 96.00% |
Colorectal Cancer | 38 | 89.47% | 48 | 93.75% | 24 | 87.50% |
Esophageal Cancer | 39 | 100% | 48 | 100% | 24 | 100% |
Gastric Cancer | 39 | 100% | 49 | 95.92% | 24 | 100% |
Hepatocellular Carcinoma | 39 | 100% | 47 | 100% | 39 | 100% |
Lung Cancer | 37 | 100% | 49 | 97.96% | 23 | 100% |
Ovarian Cancer | 37 | 94.59% | – | – | 23 | 95.65% |
Pancreatic Cancer | 39 | 100% | 46 | 100% | 24 | 100% |
Prostate Cancer | 38 | 84.21% | 773 | 85.25% | 24 | 83.33% |
Sarcoma | 38 | 100% | 48 | 95.83% | – | – |